Diabetes

The Pharmacy Times® Diabetes resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
Top news of the day from across the health care landscape.
 
[[thumbnail_alt_text]]
What is causing this patient to lose her sense of smell?
[[thumbnail_alt_text]]
Pharmacists can help with product selection and counsel on routine self-monitoring.
[[thumbnail_alt_text]]
Confirming latent autoimmune diabetes in adults and dispensing the correct tube size for triaminoclone.
[[thumbnail_alt_text]]
This intervention fosters connections with patients, identifies treatment goals, and increases adherence.
[[thumbnail_alt_text]]
Officials from the FDA have expanded the label of insulin aspart injection pumps, 100 u/mL (Fiasp, Novo Nordisk) to include use in insulin infusion pumps.
[[thumbnail_alt_text]]
Treatment depends on the patient, but adherence to the ever-changing guidelines is key.
[[thumbnail_alt_text]]
A study has found that young adults with diabetes have high rates of cardiometabolic risk factors such as adiposity, blood pressure, chronic kidney disease, and history of cardiovascular disease. These risk factors can lead to an increased disease prevalence and mortality rate among these young adults as they age.
 
[[thumbnail_alt_text]]
The study aimed to determine the association between antidepressant classes, types, and duration of use during pregnancy and the risk of gestational diabetes.
[[thumbnail_alt_text]]
Officials from the FDA have approved the Janssen Pharmaceutical Companies of Johnson & Johnson’s canagliflozin (Invokana) to reduce the risk of end-stage kidney disease (ESKD) and cardiovascular events in patients with Type 2 Diabetes and chronic kidney disease (CKD).
 
[[thumbnail_alt_text]]
The FDA has granted approval of Rybelsus (semaglutide) oral tablets 7 mg or 14 mg to Novo Nordisk. The drug is the first oral glucagon-like peptide (GLP-1) receptor protein treatment for type 2 diabetes.